Cargando…
Conjunctival melanoma with orbital invasion and liver metastasis managed with systemic immune checkpoint inhibitor therapy
A 60-year-old Caucasian female was referred for biopsy-proven amelanotic orbito-conjunctival melanoma. Map biopsies revealed residual invasive melanoma on the deep tarsal margin at the site of previous surgery. Repeat excisions were required after recurrence was detected following 3 months and 7 mon...
Autores principales: | Chang, Michael, Lally, Sara E, Dalvin, Lauren A, Orloff, Marlana M, Shields, Carol L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896557/ https://www.ncbi.nlm.nih.gov/pubmed/31755463 http://dx.doi.org/10.4103/ijo.IJO_663_19 |
Ejemplares similares
-
Update on Immune Checkpoint Inhibitors for Conjunctival Melanoma
por: Sa, Ho-Seok, et al.
Publicado: (2022) -
Conditional survival of uveal melanoma using The Cancer Genome Atlas (TCGA) classification (Simplified Version) in 1001 cases
por: Shields, Carol L., et al.
Publicado: (2021) -
An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis
por: Seedor, Rino S., et al.
Publicado: (2020) -
A case series of neuroendocrine (carcinoid) tumor metastasis to the orbit
por: Turaka, Kiran, et al.
Publicado: (2011) -
Spotlight on talimogene laherparepvec for the treatment of melanoma lesions in the skin and lymph nodes
por: Orloff, Marlana
Publicado: (2016)